Evaluating the effect of inhaled levodopa (Inbrija®) for early morning off in Parkinson’s disease
Many people with Parkinson's wake up with stiffness and slow movement because their evening medication has worn off overnight. This is known as an early morning 'off' period. Standard pills must go through the stomach, which can delay relief. This study compares an inhaled medicine called Inbrija with a fast-dissolving tablet called Madopar Quick. Inbrija delivers levodopa straight to the lungs, where it is absorbed quickly into the blood. Participants take their morning treatment and wear a special motion-sensing wristband called a PKG. This tracker records how quickly symptoms ease and how smoothly a person moves. Researchers will also ask participants how they feel and which treatment makes their morning routine easier. The goal is to see if inhaled levodopa offers a faster, more dependable way to get moving in the morning.
At a glance
What is this study about?
Living with Parkinson's disease often means dealing with 'off' times, when medication wears off and symptoms like stiffness, slowness, and tremors return. Mornings can be especially tough. After going hours without medication during sleep, many people wake up feeling stuck or finding it hard to get out of bed while waiting for their morning tablets to work.
Ordinary levodopa tablets must pass through the stomach and gut before they can reach the brain. Because Parkinson's can slow down digestion, morning pills can sometimes take a frustratingly long time to start working. Inbrija is a dry powder inhaler designed to bypass the digestive system entirely. By breathing levodopa directly into the lungs, the medicine enters the bloodstream much faster.
This trial compares Inbrija to Madopar Quick, a dissolvable tablet already used to provide quicker relief. Researchers want to find out whether the inhaler works faster, helping people switch from an 'off' state to an 'on' state with greater ease. If successful, this approach could help people with Parkinson's gain more independence and confidence at the start of each day.
Key takeaways
- Compares an inhaled medicine (Inbrija) against a fast-dissolving tablet (Madopar Quick) for morning stiffness.
- Aims to reduce the time it takes for people with Parkinson's to get moving after waking up.
- Uses a comfortable wrist tracker to measure daily movement and sleep patterns.
- Open to adults aged 18 and over who regularly wake up in an 'off' state.
- Taking part is voluntary and will not affect your standard NHS treatment.
Who may be eligible?
This study is open to adults aged 18 and older who have Parkinson's disease and regularly experience slow or stiff 'off' periods when they wake up in the morning. Both men and women are welcome to take part.
Because the study involves breathing in a powdered medicine, participants must be able to use an inhaler comfortably. People with certain chronic lung conditions or severe breathing difficulties may not be suitable.
A study doctor will check your overall health and review your current Parkinson's treatment to ensure that taking part is completely safe for you.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- You are aged 18 or older.
- You have a confirmed diagnosis of Parkinson's disease.
- You regularly wake up feeling stiff, slow, or 'off' before your first dose of medicine.
- You are able to breathe in powder using an inhaler.
- You are comfortable wearing a movement-tracking wristband and answering questions about your morning routine.
What does participation involve?
If you join this study, you will be given both the Inbrija inhaler and Madopar Quick dissolvable tablets to take at scheduled times in the morning. The medical team will show you exactly how to use the inhaler properly.
To see how well each treatment works, you will wear a lightweight wrist tracker called a PKG monitor. This device looks like a smartwatch and quietly measures your movements, tremors, and sleep patterns throughout the day and night. You will also complete short questionnaires about how easy it was to get out of bed, wash, dress, and go about your morning.
You will attend regular clinic visits where doctors will check your progress and review your monitor data. The study team will provide a clear timetable explaining how many visits are needed and how long the study will last.
Potential risks and benefits
Locations (1)
- —UnverifiedDenmark
Common questions
What is an 'off' period in Parkinson's?
An 'off' period happens when your medication levels drop, causing symptoms like muscle stiffness, tremor, and slow movement to return.
How is Inbrija different from usual levodopa pills?
Instead of being swallowed and processed by the stomach, Inbrija is inhaled into your lungs. This helps the medicine enter the blood more quickly.
What is the PKG wristband?
It is a comfortable, medical movement-tracker worn like a watch. It automatically records your mobility, stiffness, and sleep quality.
Will I have to stop taking my current Parkinson's treatments?
No, but your morning routine will be guided by the trial team. They will clearly explain any adjustments needed for your morning doses.
Does it cost anything to participate?
No, all study medicines, equipment, and medical appointments are free of charge, and travel costs can usually be reimbursed.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.